Palm Valley Capital Invests in The Clorox Company

Palm Valley Capital Management has released its investor letter for the second quarter of 2026, highlighting its investment in The Clorox Company (NYSE:CLX). The Clorox Company is a global manufacturer of consumer and professional products operating through its Health and Wellness, Household, Lifestyle, and International segments. As of July 7, 2026, The Clorox Company's shares closed at $97.41, reflecting a market capitalization of $11.78 billion. The company has experienced a one-month return of -1.92% and a 52-week return of -22.69%. Palm Valley Capital Management views The Clorox Company as a slow-growth consumer staples company with historically stable cash flows. The firm acquired a small position in the company near its lows, but the shares have since bounced.

Palm Valley Capital Management's Investment Strategy Palm Valley Capital Management generated a 1.80% return in the second quarter of 2026, underperforming the S&P SmallCap 600 index, which rose 19.7%, and the Morningstar Small Cap Total Return Index, which returned 14.0%. The firm's investment strategy primarily focused on small-cap categories, allocating 75% to cash equivalents. The company is currently seeking more small-cap opportunities that meet its return criteria and will act swiftly if market conditions improve.

The Clorox Company's Performance The Clorox Company suffered a major cyberattack in 2023, disrupting production and distribution, and causing it to lose market share in several categories. The company has been working through a large ERP implementation that distorted shipments, reduced volumes, and created inventory disruptions with retailers. In April, The Clorox Company cut its fiscal 2026 outlook. Consumers have become more price-sensitive, leading some shoppers to trade down to private-label alternatives in categories such as cleaning products and household consumables.

Expert Analysis > Palm Valley Capital Management's investment in The Clorox Company highlights the company's potential and position in the market. The firm's view of The Clorox Company as a slow-growth consumer staples company with historically stable cash flows underscores the company's attractiveness as a long-term investment opportunity.